Abstract

We developed an approach for substantial attenuation of Mycobacterium tuberculosis by prolonged culturing under gradually acidifying conditions. Bacteria subjected to acidification lost the capacity to form colonies on solid media, but readily resuscitated their growth in the murine host, providing a useful model to study in vivo development of infection mimicking latent and reactivation tuberculosis (TB) in humans. Here we characterize biomarkers of lung pathology and immune responses triggered by such attenuated bacteria in genetically TB-susceptible and resistant mice. In susceptible I/St mice, CFU counts in lungs and spleens were ~1.5-log higher than in resistant B6 mice, accompanied by diffuse pneumonia and excessive lung infiltration with highly activated CD44+CD62L- T-lymphocytes resulting in death between months 7–9 post challenge. B6 mice were characterized by development of local inflammatory foci, higher production of pro-inflammatory IL-6 and IL-11 cytokines and a more balanced T-cell activation in their lungs. CFU counts remained stable in B6 mice during the whole 18-mo observation period, and all mice survived. Thus, we established a mouse model of fatal reactivation TB vs. indefinite mycobacterial possession after identical challenge and characterized the features of immune responses in the lung tissue underlining these polar phenotypes.

Highlights

  • It is generally accepted that among immune sufficient humans not more than 3–10 per cent of individuals infected with M. tuberculosis eventually develop clinical disease [1]

  • We assessed the persistence of attenuated mycobacteria in organs of susceptible and resistant mice at month 8 post challenge and obtained mortality curves for susceptible mice which all succumbed to infection by month 10 [26]

  • We assessed whether or not dormant mycobacteria are able to kill genetically resistant mice and what are the features of lung inflammation in these mice at the very late phase of infection (18mo)

Read more

Summary

Introduction

It is generally accepted that among immune sufficient humans not more than 3–10 per cent of individuals infected with M. tuberculosis eventually develop clinical disease [1]. Since the cases of complete spontaneous mycobacterial eradication are rare [2], about 90 per cent of infected individuals without clinical manifestations comprise a reservoir of latent tuberculosis infection (LTBI). The size of this reservoir is enormous: it was estimated that approximately 25% of global population is latently infected with M. tuberculosis [3].

Methods
Results
Conclusion
Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call